Financial statements Aether Biomedical

Balance sheet of Aether Biomedical

Company age:
Age:
6 y. 10 m. 12 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of AETHER BIOMEDICAL

Year
2021
2022
2023
Total assets 16 599 369,01 13 047 276,08 46 237 558,94
A. Fixed assets 1 167 977,48 7 930 740,46 11 950 094,06
B. Current assets 15 431 391,53 5 116 535,62 34 287 464,88
C. Share capital contributions (basic funds) - - -
D. Own shares (stocks) - - -
Total liabilities 16 599 369,01 13 047 276,08 46 237 558,94
A. Equity 14 433 345,09 9 988 870,45 41 289 391,57
B. Liabilities and provisions for liabilities 2 166 023,92 3 058 405,63 4 948 167,37
I. Long-term liabilities - - 0,00
II. Short-term liabilities - 501 831,26 669 252,20
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.